Choice A rationale:

Myomectomy is a surgical procedure for removing uterine fibroids while preserving the uterus.

It is not a minimally invasive option, as it involves making an incision in the abdomen or using minimally invasive techniques like laparoscopy.

This procedure may require a longer recovery period compared to other minimally invasive options.

Choice B rationale:

Hysterectomy involves the removal of the entire uterus and is not a minimally invasive option for fibroid treatment.

It is a more invasive procedure and is typically considered when other treatment options have been exhausted or when the patient does not wish to preserve fertility.

Choice C rationale:

Uterine artery embolization (UAE) is a minimally invasive procedure used to treat uterine fibroids.

During UAE, tiny particles are injected into the uterine arteries to block blood flow to the fibroids, causing them to shrink and relieve symptoms.

This option preserves the uterus and often involves a shorter recovery period compared to surgery.

Choice D rationale:

Progestin therapy is a medication-based approach for managing symptoms associated with uterine fibroids, but it is not a minimally invasive procedure.

Progestin therapy can help control heavy menstrual bleeding and relieve pain but does not directly shrink the fibroids.

It is typically used as a temporary measure or in combination with other treatments.